Cargando…
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
SIMPLE SUMMARY: The gold standard for genetic panel test samples is considered to be tissue specimens. However, in clinical practice, tissue specimens are often unavailable. Therefore, using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable...
Autores principales: | Morikawa, Kei, Kida, Hirotaka, Handa, Hiroshi, Inoue, Takeo, Saji, Hisashi, Koike, Junki, Nakamura, Seiji, Sato, Yoshiharu, Ueda, Yumi, Suzuki, Fumihiko, Matoba, Ryo, Mineshita, Masamichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367394/ https://www.ncbi.nlm.nih.gov/pubmed/35954448 http://dx.doi.org/10.3390/cancers14153784 |
Ejemplares similares
-
EML4-ALK Gene Mutation Detected with New NGS Lung Cancer Panel CDx Using Sputum Cytology in a Case of Advanced NSCLC
por: Morikawa, Kei, et al.
Publicado: (2023) -
Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs
por: Morikawa, Kei, et al.
Publicado: (2022) -
Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer
por: Furuya, Naoki, et al.
Publicado: (2020) -
Evaluation of Droplet Countermeasures by a Particle Visualization System in Simulated Bronchoscopy
por: Morikawa, Kei, et al.
Publicado: (2021) -
RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report
por: Morikawa, Kei, et al.
Publicado: (2022)